Targets the neck of the aneurysm Designed to treat a range of aneurysm

morphologies including unruptured wide-necked

bifurcation and bifurcation aneurysms:

• Provides a combination of flow diversion at the neck of the aneurysm and flow disruption within the aneurysm sac;
• Supports neo-intimal growth across mesh at neck and subsequent thrombosis of aneurysm;
• Deployed with proven existing clinical techniques;
• A single device occlusion that is re-sheathable & re-deployable;
• Electrolytic method of detachment;
• Strong IP portfolio - 3 patents issued and 3 patents pending;
• No intra-arterial stabilizing component;
• Reduces/eliminates need for dual anti-platelet therapy;
• Simplified sizing approach compared to other intra-saccular devices (i.e. neck  and widest diameter only).

​

How safe and effective are existing treatments for wide-necked bifurcation aneurysms?

Literature based objective performance criteria for safety and effectiveness

Journal of Neurointerventional Surgery, October 11, 2017

Meta-Analysis, Fiorella et al.​

Description                                           Outcome (1yr)

Wide Neck Bifurcation Aneurysm     2,795

Complete Occlusion                            40%

Adequate Occlusion                            70%

​

Conclusion:  Conventional therapies for WNBAs are associated with relatively low rates of complete occlusion and peri-procedural complications are not uncommon. Newer therapies are needed for the treatment of these aneurysms. Until a ‘gold standard’ treatment strategy is established, these emerging technologies can be evaluated in comparison to the benchmark literature-derived OPC presented*.

Indications for Use

The Contour Neurovascular System™ is indicated for the endovascular embolization of saccular intracranial aneurysms. The Contour Neurovascular System™, Models CNS0005-XX, CNS0007-XX, CNS0009XX and CNS0011-XX, meet the essential requirements referred to in Article 3 of the MDD 93/42/EEC and are labelled with the CE Marking of conformity.